Biotech

All Articles

Analysts dig into Avidity's DMD win, exposing subtleties in information

.Avidity Biosciences pleased investors along with period 1/2 records in Duchenne muscle dystrophy (D...

Actinogen's cortisol blocker falls short stage 2 depression research study

.Actinogen Medical's cortisol blocker has actually missed out on the key endpoint of a stage 2 study...

Bivictrix makes a decision going private only means to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have actually been at the facility of numerous a billion-dollar bio...

TPG leadings up funds to $580M for financial investments throughout life scientific researches

.Possession manager TPG, which has sustained biotechs including Sionna Therapeutics and also Santa C...

Merck quits stage 3 TIGIT trial in lung cancer cells for futility

.Merck &amp Co.'s TIGIT course has actually suffered one more trouble. Months after shuttering a pha...

After a tough year, Exscientia folds right into Recursion

.After a year specified by pipe cuts, the variation of its own chief executive officer as well as la...

Cullinan, after $25M offer, hands back bispecific to Harbour

.Cullinan Rehab was actually excited sufficient with Port BioMed's bispecific invulnerable activator...

A deeper look at Brutal Biotech's Intense 15

.Within this week's incident of "The Best Line," our team are actually diving right into Brutal Biot...

Lilly experiences stage 2 failing of tau-targeting med

.The confetti is actually still flying from Eli Lilly's party commemorating the commendation of Alzh...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings an...